These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 20508616)
1. IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Tefferi A; Lasho TL; Abdel-Wahab O; Guglielmelli P; Patel J; Caramazza D; Pieri L; Finke CM; Kilpivaara O; Wadleigh M; Mai M; McClure RF; Gilliland DG; Levine RL; Pardanani A; Vannucchi AM Leukemia; 2010 Jul; 24(7):1302-9. PubMed ID: 20508616 [TBL] [Abstract][Full Text] [Related]
2. IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Pardanani A; Lasho TL; Finke CM; Mai M; McClure RF; Tefferi A Leukemia; 2010 Jun; 24(6):1146-51. PubMed ID: 20410924 [TBL] [Abstract][Full Text] [Related]
3. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable. Kim SY; Im K; Park SN; Kwon J; Kim JA; Lee DS Am J Clin Pathol; 2015 May; 143(5):635-44. PubMed ID: 25873496 [TBL] [Abstract][Full Text] [Related]
9. MOLECULAR GENETIC ABNORMALITIES IN THE GENOME OF PATIENTS WITH Ph-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA AFFECTED BY IONIZING RADIATION AS A RESULT OF THE CHORNOBYL NUCLEAR ACCIDENT. Poluben LO; Neumerzhytska LV; Klymenko SV; Fraenkel P; Balk C; Shumeiko OO Probl Radiac Med Radiobiol; 2020 Dec; 25():362-373. PubMed ID: 33361847 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India. Rabade N; Subramanian PG; Kodgule R; Raval G; Joshi S; Chaudhary S; Mascarenhas R; Tembhare P; Gujral S; Patkar N Indian J Pathol Microbiol; 2018; 61(2):209-213. PubMed ID: 29676359 [TBL] [Abstract][Full Text] [Related]
11. Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000-2018. Mejía-Ochoa M; Acevedo Toro PA; Cardona-Arias JA BMC Cancer; 2019 Jun; 19(1):590. PubMed ID: 31208359 [TBL] [Abstract][Full Text] [Related]
12. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Kilpivaara O; Levine RL Leukemia; 2008 Oct; 22(10):1813-7. PubMed ID: 18754026 [TBL] [Abstract][Full Text] [Related]
13. IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F. Tefferi A; Jimma T; Sulai NH; Lasho TL; Finke CM; Knudson RA; McClure RF; Pardanani A Leukemia; 2012 Mar; 26(3):475-80. PubMed ID: 21912393 [TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Tefferi A; Barbui T Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718 [TBL] [Abstract][Full Text] [Related]
15. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600 [TBL] [Abstract][Full Text] [Related]
16. [The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Lyu XD; Li YW; Guo Z; Xin YP; Hu JY; Fan RH; Song YP Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):35-39. PubMed ID: 31887834 [No Abstract] [Full Text] [Related]
17. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond. Michiels JJ; Berneman Z; Schroyens W; De Raeve H Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092 [TBL] [Abstract][Full Text] [Related]
18. Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children. Ismael O; Shimada A; Hama A; Sakaguchi H; Doisaki S; Muramatsu H; Yoshida N; Ito M; Takahashi Y; Akita N; Sunami S; Ohtsuka Y; Asada Y; Fujisaki H; Kojima S Pediatr Blood Cancer; 2012 Sep; 59(3):530-5. PubMed ID: 22106054 [TBL] [Abstract][Full Text] [Related]
19. Life, genes, and death in Ph- MPNs. Silver RT Blood; 2014 Oct; 124(16):2471-2. PubMed ID: 25323682 [TBL] [Abstract][Full Text] [Related]
20. Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera. Delic S; Rose D; Kern W; Nadarajah N; Haferlach C; Haferlach T; Meggendorfer M Br J Haematol; 2016 Nov; 175(3):419-426. PubMed ID: 27447873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]